Decentralized clinical trials: FDA guidance and the ‘new modus operandi’
Dr. Joe Unger reflected on how changes to clinical trials during the COVID pandemic “forced the sudden adoption of all of these procedures and, in my view, I think that their adoption is going to have a net positive impact on the entire system.”
‘More rigorous’ discussion needed about potential complications after prostate cancer therapy
Dr. Joe Unger led a study on complications after prostate cancer treatment. He said: “It’s really important for men not just to understand how commonly these complications can occur, but how far out in time they are still meaningful.”
The truth about blood tests for cancer
Drs. Ruth Etzioni and Scott Ramsey discussed multi-cancer early detection blood tests. Etzioni noted, “The future of screening is going to look different from the past” although “we’re not quite there.”
‘Stark’ finding: Cancer research in U.S. dominated by industry sponsors
Dr. Joe Unger pointed out that: “Federally sponsored, cancer clinical research has a unique role in identifying treatments that are best for patients. It’s not a role that can be supplanted by industry.”
Drug industry taking bigger role in cancer clinical trials
Dr. Joe Unger explained the scale of the cancer clinical trial funding gap: “We recognized that industry was playing an increasing role in cancer clinical research compared to decades ago. But we didn't realize the difference was this dramatic.”
You can now get a blood test to screen for colorectal cancer
Dr. Bill Grady commented on new tests to detect circulating tumor DNA in blood: “There is a lot of work going on in the field of blood-based cancer screening tests to improve on their current accuracy.
FDA approves new blood test to screen for colon cancer
Dr. Bill Grady emphasized: “What breaks my heart is that it’s preventable. One of my biggest joys is when I’m doing colonoscopy and I can take out polyps.” Grady was also quoted in stories in Axios, CNN, MedPage Today and VeryWell Health.
2024 Cancer Health 25: People who power clinical trials
A feature on leaders in cancer clinical trials included Drs. Garnet Anderson, Ruth Etzioni, Ziding Feng, Katherine Guthrie, Charles Kooperberg and Scott Ramsey for their work on the new Cancer Screening Research Network, based at Fred Hutch.
Study confirms effectiveness of 'Watch-and-Wait' approach to prostate cancer
Dr. Lisa Newcomb discussed active surveillance for prostate cancer in her new study: “We hope that this study encourages the national acceptance of active surveillance instead of immediate treatment for prostate cancer.”
Cancer is capsizing Americans’ finances. ‘I was losing everything.’
Dr. Scott Ramsey emphasized that cancer patients who file for bankruptcy have an 80% higher risk of dying from cancer than patients who don’t file. He said, “There actually was a pretty big detriment for survival.”
More patients participate in cancer clinical trials than previously estimated
Dr. Joe Unger and collaborators pointed out that in their study of cancer clinical trial participation, “these results suggest that contributions to clinical research for adults with cancer is more common than is typically realized.”
A blood test to detect cancer? Some patients are using them already
Dr. William Grady explained the limitations of new blood tests for cancer noting they are “not effective for brain cancer because brain cancer spreads rapidly, even when early and very small, so it is not often curable even at an early stage.”
One in five people with cancer participate in medical research studies, Fred Hutchinson study shows
Dr. Joe Unger underscored that “as we work to increase participation in cancer research studies and make them more accessible to patients, we need an inclusive, accurate assessment of current participation to inform these policies.”
Why are so many young people getting cancer? It’s complicated
Matthew Triplette discussed trends in people younger than age 50 getting cancer, and how he doubts there’s “some new, very dangerous cancer risk factor out there that’s causing tons of excessive cases in younger folks.”
Fred Hutch unveils results of new blood test that detects colon cancer
Dr. Rachel Issaka noted: “If people have more options that are convenient for them, they are more likely to participate in colon cancer screening, and we can pick up earlier cases where treatments are most effective.”
A blood test for colon cancer performed well in a study, expanding options for screening
Dr. Bill Grady commented on results from a study he led of a new blood test for colorectal cancer, emphasizing that “more screening should result in fewer cancer deaths.” This story ran in local outlets across the U.S.
A new way to screen for colon cancer may be on the horizon, study suggests
Dr. Bill Grady explained that colonoscopies and “stool-based tests have that kind of ‘ick’ factor related to them. We need to find tests that people are going to use.”
Fred Hutchinson Cancer Center and the National Coalition of 100 Black Women Inc. Host colorectal cancer awareness event at Seattle’s FAME Church
Dr. Rachel Issaka stressed the importance of prevention and screening: “March is colorectal cancer awareness month, and colon cancer is one of the most common cancers. But we can all do things to reduce our risk.”
AI chatbot helps smokers quit tobacco
Dr. Jonathan Bricker shared his motivation to create QuitBot.
Early-onset cancers are on the rise: Why it’s happening and what we can do
Dr. Bill Grady explained why earlier screening is not covered by insurance.
Affordable Care Act increased cancer trial participation among Medicaid-insured patients
Dr. Joe Unger found that the Medicaid expansion of the Affordable Care Act enabled many low-income individuals to become eligible for Medicaid.
At-home test or a colonoscopy? Which screening is best for you
Dr. Rachel Issaka pointed out health disparities in colorectal cancer survival.
NCI-funded clinical trials add 14.2 M life-years for patients with cancer over 4 decades
Dr. Joe Unger explained additional benefits of publicly-funded cancer clinical trials.
Women at greater risk for more severe adverse events from cancer treatments
Dr. Joe Unger commented on a study he led on treatment-associated adverse events by sex.
6 steps you can take to quit smoking and live a healthier life
Dr. Jonathan Bricker discussed smoking cessation.
Women suffer more after cancer treatments than men
Dr. Joe Unger shared his hopes for the treatment of cancer patients.
Women with breast cancer at higher risk for cardiovascular disease events, mortality
Dr. Heather Greenlee discussed her new study on breast cancer and cardiovascular risk.
Cancer leads to financial hardship, even among the privately insured
Dr. Veena Shankaran and coauthors urged more support for people with cancer.
Women see more adverse events with chemo and newer cancer treatments, study finds
Dr. Joe Unger discussed future research building on a study he led.
Even if uninsured, people with advanced cancer often face financial problems
Dr. Veena Shankaran shared findings from a recent study.
The COVID Cancer Effect
Kathy Briant and Dr. Rachel Issaka discussed how the pandemic has reduced cancer screenings.
Rachel Issaka is proud to inspire the next generation of doctors
Dr. Rachel Issaka was featured as one of PSBJ's 40 under 40.
Pioneering Gene Therapy Freed Her of Sickle Cell. Is a Cure at Hand?
Dr. Scott Ramsey commented on how the standard treatment for sickle cell disease is more costly than a new curative approach.
Researchers Investigate Molecular Clues in Puzzling Alaska Native Cancer Disparity
Dr. Riki Peters and collaborators spoke about new research to understand colorectal cancer disparities in Alaska Native people.
How to quit smoking: 5 actions you can take now 5 actions you can take now to end the addiction
Dr. Jonathan Bricker shared strategies for quitting smoking.
Videos reduce HPV vaccine hesitancy among parents
Dr. Parth Shah discussed his study on how to encourage HPV vaccination.
The COVID pandemic’s lingering impact on clinical trials
Dr. Joe Unger discussed efforts to measure whether changes to clinical trials during the pandemic affected data quality.
New Guidelines Say Colonoscopies Should Start At Age 45
Dr. Rachel Issaka gave insights on the new guidelines for colonoscopies.
A doctor trained nurse practitioners to do colonoscopies. Critics say his research exploited Black patients
Dr. Rachel Issaka critiqued a study’s consent process.
Patients with cancer living in poorer areas have worse survival outcomes
Dr. Joe Unger explained his study showing that in cancer patients, “access to guideline-based care...alone is not sufficient to eliminate disparate outcomes related to socioeconomic deprivation.”
Fred Hutch initiative Cook for Your Life brings cancer nutrition research to the kitchen
Dr. Heather Greenlee described her goal for the Cook for Your Life website.
A Colonoscopy Alternative Comes Home
Dr. Rachel Issaka described how patients should approach at-home colon cancer tests with their doctors.
Amid Pandemic, Scientists Reassess Routine Medical Care
Dr. Scott Ramsey discussed how some of the changes to health care during the pandemic may result in improved quality of care and greater efficiency.
Dismantling structural racism in medicine is good for us all
Dr. Rachel Issaka spoke with KING 5 about how structural racism affects both doctors of color and patients.
Ending systemic racism in oncology is everyone's responsibility
In a Q&A, Dr. Rachel Issaka discussed how health care professionals can dismantle systemic racism in medicine, including examining “the policies and structures within medicine that make it more difficult for minority patients to thrive.”
Quitting smoking apps that help you acknowledge your triggers work better, study shows
Dr. Jonathan Bricker explained how acknowledging and accepting cravings is the key to quitting smoking.
How the COVID-19 pandemic has changed cancer care, in 4 charts
Dr. Rachel Issaka commented on the importance of home screening tests for colorectal cancer.
Listen: Coronavirus vaccine data, saving the U.S.’s pandemic response, and systemic racism in medicine
Dr. Rachel Issaka discussed her recent essay on structural racism in academic medicine, and what should be done to change it.
FDA pilot program to communicate patient reported outcomes from cancer clinical trials
Joseph Unger commented on his new study on the impact of insurance status on health outcomes.
Black patients are underrepresented in cancer clinical trials but more likely to be enrolled in public-sponsored vs pharmaceutical-sponsored studies
Joseph Unger’s and the SWOG network's latest research illustrating that Black patients are better represented in publicly funded cancer clinical trials is discussed.
The cost of racial disparities in clinical trials
Joe Unger commented on how a lack of Black patients in clinical trials can lead to a lack of data on how drugs impact vulnerable populations.
Insurance status linked to survival benefit in cancer treatment trials
Dr. Joe Unger’s research with the SWOG network suggesting health insurance plays a role in clinical trial success for patients is discussed.
CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19
Dr. Gary Lyman’s work with the COVID-19 and Cancer Consortium is referenced, revealing that patients with active cancer have a higher risk of death after contracting SARS-CoV-2.
'Major financial hardship' hits most patients battling advanced colon cancer
New research from the Hutch's health economics group HICOR and Dr. Veena Shankaran, suggesting nearly 75% of patients with advanced colon cancer experience financial hardship as a result of treatment is discussed.
Cancer patients without insurance or Medicaid don’t experience the same benefits of clinical trials
A SWOG study led by Joseph Unger is featured, specifically findings that insurance plays a large role in whether a patient benefits from clinical trials.
As pandemic claims non-COVID patients, some face difficult decisions
Dr. Gary Lyman discussed the risk cancer patients face with COVID-19 and his work with the COVID-19 and Cancer Consortium.
The fight against COVID-19 threatens to cause collateral health damage
Rachel Issaka weighed in on the need to continue cancer and other chronic disease management and prevention work despite COVID-19.
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Dr. Gary Lyman’s comments from a panel on COVID-19 and cancer care are highlighted.
Leading experts launch COVID-19 & cancer consortium
Gary Lyman’s comments on the new COVID-19 cancer registry are discussed.
Blood test may detect multiple cancer types: Study
Dr. William Grady commented on an outside study on blood tests and cancer detection.
Cancer consortium launches COVID-19 registry in urgent appeal for data to save lives at risk from infection
Dr. Gary Lyman commented on the new COVID-19 and Cancer Consortium (CCC19) registry and how they will use COVID-19 data to inform treatment.
The blind leading the blind: COVID-19, cancer, and the need for more data
Dr. Gary Lyman discussed best practices for treating cancer patients during the COVID-19 outbreak.
Taking supplements during breast cancer treatment increase risk of death and relapse, what does this mean for patients?
Dr. Kevin Cheung provided expert commentary on the relationship between breast cancer and nutritional supplements.
Lung-MAP trial reveals genetic testing knowledge gaps among patients
Dr. Joshua Roth discussed his study on genetic testing knowledge.
Dr. Lyman on challenges with biosimilar policies
Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.
Dr. Lyman on challenges with biosimilar policies
Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.
Low-Fat Dietary Pattern Offers Long-Term Health Benefits
HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for
What does your waist say about your health? According to a new study, a lot more than you’d think.
The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates.
What we need to do to get more people with cancer into clinical trials
Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.
Lung cancer screening guidelines may miss more African Americans at risk
Dr. Jaimee Heffner provided expert commentary on a new study about lung cancer screening guidelines. This story was re-printed in several other outlets, including Business Insider.
Cost effectiveness of CAR T-Cell therapy depends on long-term outcomes
Dr. Josh Roth provided expert commentary about a study on cost of CAR-T therapy.
HBV tied to non-liver digestive-tract cancers
MedPage Today highlighted a study led by Fred Hutch’s Dr. Scott Ramsey, which showed that newly diagnosed cancer patients were unaware that they were infected with Hepatitis B and other viruses.
Listen: A special episode from the halls of the ASCO meeting
STAT interviewed Dr. Parth Shah on The Readout Loud podcast about his research on increasing HPV vaccination rates in the U.S.
Health claims in nutrition books can be a ‘volcano of nonsense.’ A new website is fighting back.
Dr. Mario Kratz provided comments on why he reviews the latest nutrition and health books for the Red Pen Reviews website.
A new study links sugary drinks with disease. The reality is more complicated
The Seattle Times cited Dr. Mario Kratz about the health impact of sugary beverages.
High-deductible health policies linked to delayed diagnosis and treatment
Dr. Veena Shankaran, co-director of Fred Hutch’s health care and economics policy research group, the Hutchinson Institute for Cancer Outcomes Research, commented on the impact of high-deductible health plans on people with cancer.
The disturbing links between too much weight and several types of cancer
Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk.
Oral blood thinner may reduce blood clots in high-risk patients with cancer
CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.
Oral blood thinner may reduce blood clots in high-risk patients with cancer
CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.
Tobacco 21 and cancer consequences
KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.
Tobacco 21 and cancer consequences
KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.
Hutchinson Institute for Cancer Outcomes Research names co-director
Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research.
Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection
This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.
Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection
This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.
Rivaroxaban decreases VTE incidence during intervention period among patients with cancer
This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.
Why do only eight percent of cancer patients in the U.S. participate in clinical trials?
This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.
Tech moves: Rhapsody adds CCO as ‘Powered by Napster’ formally launches; DreamBox hires CFO following cash infusion; and more
Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column.
Information, not urgency, boosts parents’ confidence in HPV vaccine
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
Information, not urgency, boosts parents’ confidence in HPV vaccine
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity
Undiagnosed hepatitis common among people with cancer
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity
Undiagnosed hepatitis common among people with cancer
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
What to eat – and how to feel better – during menopause
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
What to eat – and how to feel better – during menopause
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
Comorbidities associated with lower clinical trial participation
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
Comorbidities associated with lower clinical trial participation
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
5 ways to protect your prostate
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
5 ways to protect your prostate
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
Cancer comorbidities reduce clinical trial participation, new SWOG study shows
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
Cancer comorbidities reduce clinical trial enrollment, study finds
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
Cancer comorbidities reduce clinical trial participation, new SWOG study shows
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
Cancer comorbidities reduce clinical trial enrollment, study finds
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
6 vitamin myths you have to stop believing – and 2 vitamins you actually do need
Fred Hutch Dr. Marian Neuhouser provides expert comments on the benefits of multivitamins.
Study identifies 40 new genetic variants associated with colorectal cancer risk
This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.
Coping with head and neck cancer
Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.
It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet
This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.
It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet
This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.
Pricey precision medicine often financially toxic for cancer patients
Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.
Pricey precision medicine often financially toxic for cancer patients
Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.
Healthy Living: Doctors say exercise and diet can reduce risk of breast cancer
Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.
Should we rely on artificial intelligence to provide advice about cancer?
Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.
Should we rely on artificial intelligence to provide advice about cancer?
Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.
The Roots of Rural Health Disparities
This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.
The Roots of Rural Health Disparities
This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.
Opportunities, issues and challenges for biosimilars in oncology
In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.
ASCO endorses guidelines for integrative therapies during and after breast cancer treatment
Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.
Opportunities, issues and challenges for biosimilars in oncology
In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.
ASCO endorses guidelines for integrative therapies during and after breast cancer treatment
Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.
A leading oncology association says some complementary therapies helpful to women with breast cancer with HIV
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
Fred Hutch doctor comments on reducing need for breast cancer patients to undergo chemotherapy
Research presented at the American Society of Clinical Oncology (ASCO) and published in the New England Journal of Medicine suggests that new genetic testing may make it possible for 70 percent of early-stage breast cancer patients to avoid chemotherapy. Fred Hutch’s Dr. Kevin Cheung explained the study and its implications for patients.
The high cost of cancer treatment
Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.
The high cost of cancer treatment
Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.
Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
Does eating soy products increase or lower risk of breast cancer?
Dr. Marian L. Neuhouser, head of the Cancer Prevention Program at Fred Hutch, discussed possible links between soy products and breast cancer. She noted compounds found in soybeans and other plants can mimic the effects of estrogen, a prime driver of most breast cancers, but most studies have found no negative association between soy consumption and breast cancer risk.
Preventive benefit of finasteride for prostate cancer maintained for 16 years
A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.
Preventive benefit of finasteride for prostate cancer maintained for 16 years
A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.
Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved
Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.
Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved
Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.
Cognitive behavioral therapy may improve sleep during menopause
For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.
Cognitive behavioral therapy may improve sleep during menopause
For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.
Researchers on racial disparity: ‘We are failing black women with breast cancer’
In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.
Researchers on racial disparity: ‘We are failing black women with breast cancer’
In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.
Many women with breast cancer get too much testing and treatment
Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.
Many women with breast cancer get too much testing and treatment
Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.
A cancer conundrum: too many drug trials, too few patients
Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials
A cancer conundrum: too many drug trials, too few patients
Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials
More than 3 million life-years added over 60 years as a result of SWOG clinical trials
An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member
More than 3 million life-years added over 60 years as a result of SWOG clinical trials
An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Medicine's movable feast: What jumping genes can teach us about treating disease
Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses
Medicine's movable feast: What jumping genes can teach us about treating disease
Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses
Brain cancer like McCain's has hundreds of experimental therapies (with little success)
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
Brain cancer like McCain's has hundreds of experimental therapies (with little success)
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
Study informs use of NSAID benefit in colon cancer
Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors
Study informs use of NSAID benefit in colon cancer
Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors
5 man-killing cancers you might not spot until it's too late
Article on several cancers that men should be aware of, including comments from Dr. William Grady on symptoms and treatment for colorectal cancer
5 man-killing cancers you might not spot until it's too late
Article on several cancers that men should be aware of, including comments from Dr. William Grady on symptoms and treatment for colorectal cancer
NCI-funded trials have extended lives of US patients with cancer
Coverage of the Fred Hutch-led study that found trials run by the SWOG collaborative group saved an estimated 3.34 million years of life for cancer patients. Quotes study author Dr. Joseph Unger
NCI-funded trials have extended lives of US patients with cancer
Coverage of the Fred Hutch-led study that found trials run by the SWOG collaborative group saved an estimated 3.34 million years of life for cancer patients. Quotes study author Dr. Joseph Unger
Big returns on small cancer research investment, study suggests
Fred Hutch-led study found that trials run by the National Cancer Institute-supported SWOG collaborative group have saved an estimated 3.34 million years of life. Article quotes study author Dr. Joseph Unger on how the team measured the program's benefit
Big returns on small cancer research investment, study suggests
Fred Hutch-led study found that trials run by the National Cancer Institute-supported SWOG collaborative group have saved an estimated 3.34 million years of life. Article quotes study author Dr. Joseph Unger on how the team measured the program's benefit
Most cancer mutations arise from ‘bad luck,’ but many cases still preventable, researchers say
Fred Hutch biostatistician Dr. Ross Prentice comments on a controversial study on the role DNA mutations play in cancer risk. Scientific American also ran this story
Most cancer mutations arise from ‘bad luck,’ but many cases still preventable, researchers say
Fred Hutch biostatistician Dr. Ross Prentice comments on a controversial study on the role DNA mutations play in cancer risk. Scientific American also ran this story
For breast cancer survivors, eating soy tied to a longevity boost
Quotes Dr. Marion Neuhouser on a study that found some positive benefits of soy consumption among breast cancer survivors
For breast cancer survivors, eating soy tied to a longevity boost
Quotes Dr. Marion Neuhouser on a study that found some positive benefits of soy consumption among breast cancer survivors
Exercise reduces death from breast cancer relapse by 40 per cent
Article on breast cancer and exercise study quotes Dr. Anne McTiernan
Who's ordering tests and imaging for breast cancer survivors?
Julia Walker, a member of the Hutchinson Institute for Cancer Outcomes Research, is quoted explaining a study looking into why breast cancer patients may be receiving biomarker testing or imaging that doesn't adhere to recommendations
Food, body image, and self worth with a nutrition doctor
Interview with Dr. Anne McTiernan, a cancer prevention researcher at Fred Hutch who recently wrote a memoir, "Starved: A Nutrition Doctor's Journey from Empty to Full," about her early-childhood of neglect and near-starvation and how she overcame these obstacles to become a leading nutrition researcher
PEGPH20 extends PFS in advanced pancreatic cancer
Dr. Sunil Hingorani, principal investigator of a trial for pancreatic cancer drug PEGPH20, is quotes on recent clinical trial results
For a healthy diet, be choosy about your cheese
Quotes Fred Hutch nutritional epidemiologist Dr. Marian Neuhouser
Many Medicare cancer patients hit by high out-of-pocket costs
Quotes Fred Hutch health care economist Dr. Scott Ramsey about a Johns Hopkins study that found cancer patients with only Medicare coverage face steep out-of-pocket costs
For a healthy diet, be choosy about your cheese
Quotes Fred Hutch nutritional epidemiologist Dr. Marian Neuhouser
Many Medicare cancer patients hit by high out-of-pocket costs
Quotes Fred Hutch health care economist Dr. Scott Ramsey about a Johns Hopkins study that found cancer patients with only Medicare coverage face steep out-of-pocket costs
This app could triple a smoker's chance of quitting, new study finds
Article about a study of an app developed by Dr. Jonathan Bricker and 2Morrow that found it could up to triple a smoker's chances of quitting
This app could triple a smoker's chance of quitting, new study finds
Article about a study of an app developed by Dr. Jonathan Bricker and 2Morrow that found it could up to triple a smoker's chances of quitting
Differences in risk factor estimates for prostate cancer
Coverage of a prostate cancer study by Drs. Catherine Tangen and colleagues that was published recently in the Journal of Clinical Oncology
Differences in risk factor estimates for prostate cancer
Coverage of a prostate cancer study by Drs. Catherine Tangen and colleagues that was published recently in the Journal of Clinical Oncology
Financial toxicity: 1 in 3 cancer patients have to turn to friends or family to pay for care
Opinion piece by Drs. Scott Ramsey and Veena Shankaran of the Hutchinson Institute for Cancer Outcomes Research
Financial toxicity: 1 in 3 cancer patients have to turn to friends or family to pay for care
Opinion piece by Drs. Scott Ramsey and Veena Shankaran of the Hutchinson Institute for Cancer Outcomes Research
Breast cancer survivors not always clear about follow up care
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about confusion among breast cancer patients about follow-up care
Breast cancer survivors not always clear about follow up care
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about confusion among breast cancer patients about follow-up care
$2.5 million grant awarded for childhood obesity study in Lower Valley
Coverage of a $2.5 million grant to Dr. Linda Ko and colleagues at Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
$2.5 million grant awarded for childhood obesity study in Lower Valley
Coverage of a $2.5 million grant to Dr. Linda Ko and colleagues at Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
Cancer deaths rose during the recession. But why?
Quotes Fred Hutch health economist Dr. Scott Ramsey
Cancer deaths rose during the recession. But why?
Quotes Fred Hutch health economist Dr. Scott Ramsey
Value in cancer care must 'start with patients, not dollars'
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Value in cancer care must 'start with patients, not dollars'
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
In menopausal women, phone-based cognitive behavioral intervention reduces insomnia, helps with hot flashes
Coverage of a study by Dr. Katherine Guthrie of Fred Hutch and Dr. Susan McCurry of the University of Washington School of Nursing, published recently in JAMA Internal Medicine
In menopausal women, phone-based cognitive behavioral intervention reduces insomnia, helps with hot flashes
Coverage of a study by Dr. Katherine Guthrie of Fred Hutch and Dr. Susan McCurry of the University of Washington School of Nursing, published recently in JAMA Internal Medicine
Should you eat more full-fat dairy?
Quotes Dr. Mario Kratz of the Public Health Sciences Division
Federal grant will help battle childhood obesity
Coverage of a $2.5 million grant to Dr. Linda Ko of Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
Federal grant will help battle childhood obesity
Coverage of a $2.5 million grant to Dr. Linda Ko of Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
New FDA e-cigarette rules leave local fans, foes sharply divided
Quotes Dr. Jonathan Bricker, a smoking-cessation expert at Fred Hutch
New FDA e-cigarette rules leave local fans, foes sharply divided
Quotes Dr. Jonathan Bricker, a smoking-cessation expert at Fred Hutch
People in research: Dr. Jonathan Bricker wants to help people quit smoking
Profile of Hutch smoking-cessation researcher Dr. Jonathan Bricker
People in research: Dr. Jonathan Bricker wants to help people quit smoking
Profile of Hutch smoking-cessation researcher Dr. Jonathan Bricker
Drinking, weight gain and processed meats could raise stomach cancer risk
Quotes Dr. Anne McTiernan about newly reported risk factors for stomach cancer
How to choose the healthiest fish
Quotes Fred Hutch nutrition researcher Dr. Marian Neuhouser about the health benefits of omega 3s found in foods such as fish
Tackling the financial toll of cancer, one patient at a time
Quotes Fred Hutch health economist Dr. Scott Ramsey
Seattle visit sparks effort to snuff China's smoking habit -- with an app
Article about Fred Hutch smoking-cessation researcher Dr. Jonathan Bricker and his collaboration with researchers at the University of Beijing to bring quit-smoking apps to people in China, where 315 million light up regularly and more than 1 million die from the habit each year
Tackling the financial toll of cancer, one patient at a time
Quotes Fred Hutch health economist Dr. Scott Ramsey
Seattle visit sparks effort to snuff China's smoking habit -- with an app
Article about Fred Hutch smoking-cessation researcher Dr. Jonathan Bricker and his collaboration with researchers at the University of Beijing to bring quit-smoking apps to people in China, where 315 million light up regularly and more than 1 million die from the habit each year
The burden of cancer isn't just cancer
Article about the financial toxicity of cancer quotes Fred Hutch health economist Dr. Scott Ramsey, whose research has found that people with cancer are 2.65 times more likely to file for bankruptcy that those without cancer
The burden of cancer isn't just cancer
Article about the financial toxicity of cancer quotes Fred Hutch health economist Dr. Scott Ramsey, whose research has found that people with cancer are 2.65 times more likely to file for bankruptcy that those without cancer
Socioeconomics affect participation in cancer clinical trials
Coverage of a recent JAMA Oncology paper by Dr. Joseph Unger
Socioeconomics affect participation in cancer clinical trials
Coverage of a recent JAMA Oncology paper by Dr. Joseph Unger
Why vitamin E is dangerous for your prostate health
Quotes Dr. Alan Kristal of the Public Health Sciences Division
Conservative strategy alone makes PSA cost-effective
Coverage of a recent study by Drs. Ruth Etzioni and Joshua Roth
Positive phase 3 trials more often cited, published in high-impact journals
Article about a recent study by Dr. Joe Unger, a SWOG biostatistician based in the Public Health Sciences Division at Fred Hutch
Positive phase 3 trials more often cited, published in high-impact journals
Article about a recent study by Dr. Joe Unger, a SWOG biostatistician based in the Public Health Sciences Division at Fred Hutch
Negative clinical trial results are still quite important
Coverage of a study by Dr. Joe Unger, a biostatistician in the SWOG Statistical Center at Fred Hutch, on the positive scientific contributions of negative clinical trial results
Negative clinical trial results are still quite important
Coverage of a study by Dr. Joe Unger, a biostatistician in the SWOG Statistical Center at Fred Hutch, on the positive scientific contributions of negative clinical trial results
Are carbs as bad as red meat and cigarettes when it comes to lung cancer?
Quotes cancer prevention and nutrition researcher Dr. Marian Neuhouser
Are carbs as bad as red meat and cigarettes when it comes to lung cancer?
Quotes cancer prevention and nutrition researcher Dr. Marian Neuhouser
Cancer's financial burden tied to poorer survival, study finds
Quotes Dr. Scott Ramsey about his research into the link between cancer, bankruptcy and increased mortality
World Cancer Day: How to prevent cancer
Interview, in Spanish, about cancer prevention tips with Fred Hutch's Kathy Briant on World Cancer Day (interview broadcast Feb. 4, posted Feb. 12)
A good weight loss program is hard to find online
Quotes Fred Hutch cancer prevention expert Dr. Anne McTiernan
Seattle families face question: How much would you pay to live?
Interview with Fred Hutch health economists Drs. Scott Ramsey and Gary Lyman about the high cost of pharmaceutical drugs and how patients can be forced into bankruptcy in order to live
5 foods that may help lower your cancer risk
Quotes Dr. Johanna Lampe about the cancer-fighting properties of Brussels sprouts and other crucifers
Seattle families face question: How much would you pay to live?
Interview with Fred Hutch health economists Drs. Scott Ramsey and Gary Lyman about the high cost of pharmaceutical drugs and how patients can be forced into bankruptcy in order to live
5 foods that may help lower your cancer risk
Quotes Dr. Johanna Lampe about the cancer-fighting properties of Brussels sprouts and other crucifers
What next? Cancer groups offer a map for breast cancer survivors
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about new guidelines for cancer survivors issued today
What next? Cancer groups offer a map for breast cancer survivors
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about new guidelines for cancer survivors issued today
ASCO University offers resources for palliative and team-based care
Quotes Dr. Gary Lyman of the Hutchinson Institute for Cancer Outcomes Research about his participation on a panel that aimed to provide practical recommendations for identifying and evaluating patients with cancer-related fatigue
ASCO University offers resources for palliative and team-based care
Quotes Dr. Gary Lyman of the Hutchinson Institute for Cancer Outcomes Research about his participation on a panel that aimed to provide practical recommendations for identifying and evaluating patients with cancer-related fatigue
Costs deter low-income patients from participating in clinical trials
Coverage of a recent study by Dr. Joe Unger
Costs deter low-income patients from participating in clinical trials
Coverage of a recent study by Dr. Joe Unger
Want more patients in your clinical trials? Then pay them
Article about a study by Dr. Joe Unger quotes him about his research
Want more patients in your clinical trials? Then pay them
Article about a study by Dr. Joe Unger quotes him about his research
Study success hints at pancreatic cancer immunotherapy promise
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues that found immunotherapy can improve survival by more than 75 percent in mice with pancreatic cancer
Immunotherapy for pancreatic cancer boosts survival by more than 75% in preclinical models
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues
Immunotherapy for pancreatic cancer boosts survival by more than 75% in preclinical models
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues
Why are black breast cancer patients left out of clinical trials?
Article about a study by Dr. Joe Unger
Poorer cancer patients may be less likely to join a clinical trial
Quotes Dr. Joe Unger about his research
More evidence poor cancer patients don't join clinical trials
Quotes Dr. Joe Unger about his research
Talking to kids about smoking risks may help parents quit
Article quotes Dr. Jonathan Bricker
Why are black breast cancer patients left out of clinical trials?
Article about a study by Dr. Joe Unger
Poorer cancer patients may be less likely to join a clinical trial
Quotes Dr. Joe Unger about his research
More evidence poor cancer patients don't join clinical trials
Quotes Dr. Joe Unger about his research
Talking to kids about smoking risks may help parents quit
Article quotes Dr. Jonathan Bricker
App can help smokers kick the habit
Q-and-A with Dr. Jonathan Bricker about his smoking-cessation research
Black women more likely to get wrong breast cancer care, study confirms
Quotes Dr. Lu Chen about her research
App can help smokers kick the habit
Q-and-A with Dr. Jonathan Bricker about his smoking-cessation research
Black women more likely to get wrong breast cancer care, study confirms
Quotes Dr. Lu Chen about her research
Another study finds kids who vape smoke real tobacco, too
Quotes Dr. Jonathan Bricker about the dangers of e-cigs
Another study finds kids who vape smoke real tobacco, too
Quotes Dr. Jonathan Bricker about the dangers of e-cigs
A cure for cancer
Interview with Dr. Gary Gilliland, president and director of Fred Hutch, about his vision of the future of cancer care and the promise of immune-based therapies
A cure for cancer
Interview with Dr. Gary Gilliland, president and director of Fred Hutch, about his vision of the future of cancer care and the promise of immune-based therapies
Lost colonies
Article about the challenges of growing bacteria in the lab mentions the research of Dr. David Fredricks, a bacteriologist at the Hutch
Lost colonies
Article about the challenges of growing bacteria in the lab mentions the research of Dr. David Fredricks, a bacteriologist at the Hutch
China's first lady focuses on global health in Fred Hutch tour
Coverage of the first lady of China's Fred Hutch visit quotes Dr. Gary Gilliland, Fred Hutch president and director, and smoking-cessation researcher Dr. Jonathan Bricker
China's first lady focuses on global health in Fred Hutch tour
Coverage of the first lady of China's Fred Hutch visit quotes Dr. Gary Gilliland, Fred Hutch president and director, and smoking-cessation researcher Dr. Jonathan Bricker
Back to the future: Chemotherapy dosing in overweight and obese patients with cancer
Commentary by Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research, on the impact of obesity in chemotherapy dosing
Back to the future: Chemotherapy dosing in overweight and obese patients with cancer
Commentary by Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research, on the impact of obesity in chemotherapy dosing
With new tools, Adaptive Bio ready to bolt together a drug business
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
With new tools, Adaptive Bio ready to bolt together a drug business
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Bicyclists ride against cancer
Photos from the Obliteride fundraising event for Fred Hutch
Bicyclists ride against cancer
Photos from the Obliteride fundraising event for Fred Hutch
'What I'm doing on my summer vacation' (#5 in a series) -- Beti Thompson, Ph.D.
Profile of Fred Hutch public health researcher Dr. Beti Thompson, who is training for and participating in this weekend's Obliteride, an annual cycling fundraiser for the Hutch
'What I'm doing on my summer vacation' (#5 in a series) -- Beti Thompson, Ph.D.
Profile of Fred Hutch public health researcher Dr. Beti Thompson, who is training for and participating in this weekend's Obliteride, an annual cycling fundraiser for the Hutch
Here’s what cancer looks like to African-Americans
Story on the African-American cancer experience focuses on breast cancer survivor and advocate Bridgette Hempstead of Cierra Sisters, who works as a consultant with Fred Hutch’s Dr. Rachel Ceballos to tailor cancer survivorship programs for minority communities. Ceballos commented that many survivors don’t deal with the emotional aspects of their diagnosis until long after treatment is over.
Here’s what cancer looks like to African-Americans
Story on the African-American cancer experience focuses on breast cancer survivor and advocate Bridgette Hempstead of Cierra Sisters, who works as a consultant with Fred Hutch’s Dr. Rachel Ceballos to tailor cancer survivorship programs for minority communities. Ceballos commented that many survivors don’t deal with the emotional aspects of their diagnosis until long after treatment is over.
‘Navigators’ for cancer patients: A nice perk or something more?
Article quotes Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research
‘Navigators’ for cancer patients: A nice perk or something more?
Article quotes Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research
No proof e-cigs can help you stop smoking
Fred Hutch smoking-cessation expert Dr. Jonathan Bricker is quoted
No proof e-cigs can help you stop smoking
Fred Hutch smoking-cessation expert Dr. Jonathan Bricker is quoted
How a husband's cancer diagnosis inspired this founder to build a successful business
Article about a company called DataStat, which helps researchers automate their workflow, mentions its clients include Fred Hutch, which uses the software to help workers in Zambia organize HIV and AIDS data collection across 21 communities
How a husband's cancer diagnosis inspired this founder to build a successful business
Article about a company called DataStat, which helps researchers automate their workflow, mentions its clients include Fred Hutch, which uses the software to help workers in Zambia organize HIV and AIDS data collection across 21 communities
Seattle's Adaptive Biotechnologies raises whopping $195 million venture fund
Article about Fred Hutch spinoff company Adaptive Biotechnologies
Seattle's Adaptive Biotechnologies raises whopping $195 million venture fund
Article about Fred Hutch spinoff company Adaptive Biotechnologies
The mindful geek
Article about Fred Hutch's Dr. Jonathan Bricker, a smoking-cessation expert who is a finalist for GeekWire's "Geek of the Year Award"; online voting goes through the end of today
The mindful geek
Article about Fred Hutch's Dr. Jonathan Bricker, a smoking-cessation expert who is a finalist for GeekWire's "Geek of the Year Award"; online voting goes through the end of today
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
U.S. clears first copycat biotech drug, jolting sector
Article quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Oral bisphosphonate use reduces risk of postmenopausal endometrial cancer
Article about a study led by Dr. Polly Newcomb
U.S. clears first copycat biotech drug, jolting sector
Article quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Oral bisphosphonate use reduces risk of postmenopausal endometrial cancer
Article about a study led by Dr. Polly Newcomb
Nutrition panel urges Americans to eat green
Quotes Dr. Marian Neuhouser, a Fred Hutch nutritional epidemiologist who participated in an expert panel that has updated recommendations for U.S. dietary guidelines
Nation's top nutrition panel: the American diet is killing us
Quotes Dr. Marian Neuhouser about the latest U.S. dietary recommendations that she helped draft
Nutrition panel urges Americans to eat green
Quotes Dr. Marian Neuhouser, a Fred Hutch nutritional epidemiologist who participated in an expert panel that has updated recommendations for U.S. dietary guidelines
Nation's top nutrition panel: the American diet is killing us
Quotes Dr. Marian Neuhouser about the latest U.S. dietary recommendations that she helped draft
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Eat your fruits and veggies. That's a good way to help prevent cancer.
Quotes Dr. Marian Neuhouser
Looking for that fruit or vegetable that might prevent cancer?
Quotes nutritional epidemiologist Dr. Marian Neuhouser
Eat your fruits and veggies. That's a good way to help prevent cancer.
Quotes Dr. Marian Neuhouser
Looking for that fruit or vegetable that might prevent cancer?
Quotes nutritional epidemiologist Dr. Marian Neuhouser
The new year is the perfect time to quit smoking
Interview with Dr. Jonathan Bricker about ways to kick the smoking habit in the new year, including participating in his WebQuit.org online study (his segment starts about 16 minutes into the show and runs about 16 minutes)
The new year is the perfect time to quit smoking
Interview with Dr. Jonathan Bricker about ways to kick the smoking habit in the new year, including participating in his WebQuit.org online study (his segment starts about 16 minutes into the show and runs about 16 minutes)